Correspondence 0001104659-22-129432 from PaxMedica, Inc. (PXMD) (CIK 0001811623)
PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: Dec. 22, 2022 · CIK: 0001811623 · Accession: 0001104659-22-129432
AI Filing Summary & Sentiment
File numbers found in text: 333-268882
Letter
Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission Attention: Tyler Howes PaxMedica, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-268882
Re:
Dear Mr. Howes,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 27, 2022, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Dechert LLP, Attention: Anna Tomczyk, by facsimile to (212) 698-3599.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616 or Anna Tomczyk at (212) 641-5626.
If you have any questions regarding this request, please contact David Rosenthal at (212) 698-3616 or Anna Tomczyk of Dechert LLP at (212) 641-5626.
Sincerely,
PAXMEDICA, INC.
Show Raw Text
CORRESP
1
filename1.htm
December 22, 2022
Office of Life Sciences
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Tyler Howes
Re:
PaxMedica, Inc.
Acceleration Request for Registration Statement on Form S-1
File No. 333-268882
Dear Mr. Howes,
Pursuant to Rule 461
under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby
requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated
to December 27, 2022, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert
LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request,
the Company acknowledges that it is aware of its responsibilities under the Act. We also respectfully request that a copy of the written
order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel,
Dechert LLP, Attention: Anna Tomczyk, by facsimile to (212) 698-3599.
Once the Registration Statement
is effective, please orally confirm the event with our counsel, Dechert LLP, by calling David Rosenthal at (212) 698-3616 or Anna Tomczyk
at (212) 641-5626.
If you have any questions
regarding this request, please contact David Rosenthal at (212) 698-3616 or Anna Tomczyk of Dechert LLP at (212) 641-5626.
Sincerely,
PAXMEDICA, INC.
/s/ Howard Weisman
Howard Weisman
Chief Executive Officer
cc:
David S. Rosenthal, Dechert LLP
Anna Tomczyk, Dechert LLP